NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

The NIH Exploratory or Developmental Research Project Grant, administered by the National Institutes of Health under the U.S. Department of Health and Human Services, is a federal funding opportunity designed to support early stage, high risk, and innovative research across a broad range of biomedical, behavioral, and clinical science domains. This program involves participation from numerous NIH Institutes and Centers, each contributing to the overarching mission of advancing scientific knowledge to improve human health. The initiative reflects NIH priorities to stimulate novel ideas and exploratory investigations that may not yet have extensive preliminary data but show potential for significant impact. The primary purpose of this grant mechanism is to encourage the development of new research directions, experimental approaches, and technological innovations. Projects supported under this program are expected to be exploratory in nature and distinct from traditional large scale research efforts. The funding supports studies that test feasibility, establish proof of concept, or explore innovative hypotheses. These projects may involve considerable uncertainty or risk but are intended to generate breakthroughs, new tools, or transformative methodologies that could influence future research directions. Funding under this program is provided as a grant instrument with a maximum project period of two years. The total direct costs requested across the entire project period may not exceed 275000 dollars, with a limit of 200000 dollars in any single year. The funding is intended to support a wide range of allowable research activities consistent with NIH policies, including personnel, equipment, and other project related expenses. Cost sharing is not required for this funding opportunity, which lowers barriers to entry for eligible applicants. Eligibility for this grant is broad and inclusive, encompassing public and private institutions of higher education, nonprofit organizations with or without federal tax exempt status, for profit entities including small businesses, and various levels of government including state, local, and tribal entities. Foreign organizations and non domestic components of U.S. organizations are also eligible to apply, though restrictions apply to foreign subawards. Individual researchers must be affiliated with eligible organizations and must possess the skills and resources necessary to conduct the proposed research. Required registrations include SAM, Grants.gov, eRA Commons, and ORCID, all of which must be completed prior to submission. Applications must be submitted electronically through approved systems such as Grants.gov, ASSIST, or institutional system to system solutions. Applicants are required to follow detailed instructions provided in the NIH application guide, including preparation of research plans, budgets, data management and sharing plans, and human subjects or animal research documentation where applicable. The review process is based on peer evaluation focusing on significance, innovation, rigor, feasibility, and investigator qualifications. Projects are assessed for their potential to make meaningful contributions to scientific knowledge and public health. The application timeline follows standard NIH submission cycles with multiple due dates each year, typically occurring in February, June, and October for new applications. Each cycle includes subsequent review, advisory council consideration, and projected start dates. Applications must be submitted by 500 PM local time on the due date. The funding opportunity remains active through January 2028, and applicants are encouraged to apply early to allow time for corrections. Awards are contingent on scientific merit, availability of funds, and alignment with NIH priorities, with final funding decisions made after multi level review.

Focus on innovation and significance ensure feasibility and strong scientific rationale align with NIH mission and clearly justify approach and impact